AI can create gene therapy delivery systems thousands of times better than human attempts or evolution's billions years of work on capsids. (Creating bottom-up RNA transfer vehicles from synthetic protein assemblies, Nature)
Summary
AI-designed synthetic protein assemblies enable gene therapy delivery systems far superior to natural capsids, as reported in a Nature paper.
View Cached Full Text
Cached at: 09/10/26, 12:28 PM
Similar Articles
AI creates first synthetic viruses
AI has created the first synthetic viruses, a significant breakthrough in synthetic biology that raises biosecurity concerns.
@Junioryu136689: Nature Biotechnology: AI is starting to design not just proteins, but where proteins go inside the cell. DeepSCan learn…
DeepSCan is a new AI model that learns the rules of cell-surface display and generates novel membrane display modules, several outperforming strong natural sequences, marking a step toward programmable cellular engineering.
How AI helps scientists design the next generation of medicines
AI is accelerating biologic drug design by predicting candidate molecules and enabling multi-target therapies, with potential to cut discovery timelines by 50% and target previously undruggable diseases.
Putting money where their mouth is: Anthropic’s Claude autonomously designs disease-targeting proteins with real wet-lab proof, hitting a 35% success rate vs 10–15% human average
Anthropic's Claude AI autonomously designs disease-targeting proteins with a 35% success rate in wet-lab validation, surpassing the human average of 10-15%.
@Nature: Nature research paper: AI-redesigned starting points and outcomes enhance protein evolution
This Nature research paper presents an AI method that redesigns starting points and outcomes to enhance protein evolution.